TABLE 2.
Background of the 207 Patients
| Group B (2000–2005) | Group A (2006–2016) | |
| Male: female | 38:16 | 98:55 |
| Age, yrs | 45–81, 62.4 ± 8.7 | 36–89, 68.4 ± 10.7 |
| Affected level | ||
| Cervical | 15 | 12 |
| Thoracic | 23 | 96 |
| Lumbosacral | 16 | 45 |
| Pathology | ||
| Adenocarcinoma | 30 | 104 |
| Squamous | 14 | 19 |
| Small cell | 7 | 23 |
| Others | 3 | 7 |
| Tokuhashi score | ||
| General condition | ||
| 0 | 0 | 23 |
| 1 | 5 | 29 |
| 2 | 49 | 101 |
| Number of extraspinal bone metastases foci | ||
| 0 | 24 | 99 |
| 1 | 6 | 17 |
| 2 | 24 | 37 |
| Number of metastases in the vertebral body | ||
| 0 | 18 | 103 |
| 1 | 10 | 19 |
| 2 | 26 | 31 |
| Metastases to the major internal organs | ||
| 0 | 42 | 132 |
| 1 | 0 | 0 |
| 2 | 12 | 21 |
| Total score | 1–10, 5.4 ± 2.0 | 1–10, 4.6 ± 1.9 |
| 0–8 | 51 | 156 |
| 9–10 | 3 | 7 |
| VAS (100 mm) | 35–100, 80.4 ± 10.5 | 29–100, 76.5 ± 11.5 |
| ASIA classification | ||
| A | 1 | 0 |
| B | 5 | 0 |
| C | 14 | 20 |
| D | 17 | 10 |
| E | 17 | 123 |